Caitlin Kontulis
Finanzdirektor/CFO bei PHIO PHARMACEUTICALS CORP.
Vermögen: 7 514 $ am 30.04.2024
Profil
Caitlin Kontulis is currently working as the Secretary, VP-Finance & Administration at Phio Pharmaceuticals Corp.
Previously, she worked as the Interim Chief Accounting Officer at Galena Biopharma, Inc. She completed her graduate degree from Northeastern University in 2008 and her undergraduate degree from Bryant University in 2007.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 10 643 ( 0,23% ) | 7 514 $ | 30.04.2024 |
Aktive Positionen von Caitlin Kontulis
| Unternehmen | Position | Beginn |
|---|---|---|
| PHIO PHARMACEUTICALS CORP. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Caitlin Kontulis
| Unternehmen | Position | Ende |
|---|---|---|
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Ausbildung von Caitlin Kontulis
| Bryant University | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PHIO PHARMACEUTICALS CORP. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
